European watchdogs pull Mylan, Abbott generics on contractor’s data problems

Here’s another black mark against the pharma industry in India. European regulators are barring a slate of generic drugs whose approvals relied on data generated by India’s GVK Biosciences.

http://www.fiercepharma.com/story/european-watchdogs-pull-mylan-abbott-generics-contractors-data-problems/2014-12-08

If you don't comment, I'll just assume you agree with me

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s